Intec Parent Inc. (NTEC) NASDAQ CAPITAL MARKET

$9.63 0 (0.00%)

Market Cap: $70.98M

As of 08/03/21 12:00 AM EDT. Market open.

(NTEC)

Intec Parent Inc. (NTEC) NASDAQ CAPITAL MARKET

$9.63 0 (0.00%)

Market Cap: $70.98M

As of 08/03/21 12:00 AM EDT. Market open.

Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Company's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and specific release ... read more

Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Company's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and specific release mechanism. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Jeffrey Meckler
Full Time Employees
40
URL
Address
12 Hartom Street, Jerusalem, Har Hotzvim, 777512.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Jeffrey Meckler
Full Time Employees
40
Address
12 Hartom Street, Jerusalem, Har Hotzvim, 777512.
KEY STATS
Open
$9.81
Previous Close
$9.63
Days Range
$9.59 - $11.10
52 week range
$8.80 - $36.80
Volume
0
Avg. Volume (30 days)
2,095,733
Market Cap
$70.98M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
7,370,883
Open
$9.81
Previous Close
$9.63
Days Range
$9.59 - $11.10
52 week range
$8.80 - $36.80
Volume
0
Avg. Volume (30 days)
2,095,733
Market Cap
$70.98M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
7,370,883

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR INTEC PARENT INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Dexcel Pharma Technologies Ltd. 10% Owner Jan 31, 2020 Sale $0.31 725,951 224,319 4,424,897 Feb 04, 2020, 06:41 PM
Dexcel Pharma Technologies Ltd. 10% Owner Feb 04, 2020 Sale $0.29 110,000 31,900 4,234,897 Feb 04, 2020, 06:41 PM
Dexcel Pharma Technologies Ltd. 10% Owner Feb 03, 2020 Sale $0.32 80,000 25,440 4,344,897 Feb 04, 2020, 06:41 PM
Silberman Issac Director Nov 19, 2019 Sale $0.50 1,000 504 4,000 Nov 21, 2019, 05:00 PM
Meckler Jeffrey A Chief Executive Officer Aug 28, 2019 Buy $0.68 20,000 13,620 196,761 Aug 29, 2019, 04:16 PM
MADDALUNA ANTHONY J Director Aug 27, 2019 Buy $0.47 25,000 11,750 53,570 Aug 29, 2019, 04:16 PM
KOZARICH JOHN W Director Aug 23, 2019 Buy $0.46 100,000 45,900 151,761 Aug 27, 2019, 04:20 PM
Meckler Jeffrey A Chief Executive Officer Aug 23, 2019 Buy $0.46 100,000 45,700 176,761 Aug 27, 2019, 04:18 PM
Buy Sale Option Exercise
Owner Relationship Date Value($)
Dexcel Pharma Technologies Ltd. 10% Owner 01/31/2020 224,319
Dexcel Pharma Technologies Ltd. 10% Owner 02/04/2020 31,900
Dexcel Pharma Technologies Ltd. 10% Owner 02/03/2020 25,440
Silberman Issac Director 11/19/2019 504
Meckler Jeffrey A Chief Executive Officer 08/28/2019 13,620
MADDALUNA ANTHONY J Director 08/27/2019 11,750
KOZARICH JOHN W Director 08/23/2019 45,900
Meckler Jeffrey A Chief Executive Officer 08/23/2019 45,700